36.99

2.35% 0.85

After Hours: 36.99

Supernus Pharmaceuticals Inc (SUPN)

Overview News Price History Option Chain Financials Why SUPN Down? Discussions Forecast

Supernus Pharmaceuticals Inc stock is traded at $36.99, with a volume of 461.11K. It is up +2.35% in the last 24 hours and up +9.02% over the past month. Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Previous Close:

$36.14

Open:

$36.43

24h Volume:

461.11K

Relative Volume:

1.32

Market Cap:

$2.03B

Revenue:

$651.97M

Net Income/Loss:

$59.71M

P/E Ratio:

50.67

EPS:

0.73

Net Cash Flow:

$172.03M

1W Performance:

+2.41%

1M Performance:

+9.02%

6M Performance:

+34.46%

1Y Performance:

+36.54%

1-Day Range:

$36.03

$37.23

1-Week Range:

$35.53

$37.23

52-Week Range:

$25.53

$39.37

Supernus Pharmaceuticals Inc Stock (SUPN) Company Profile

Name

Supernus Pharmaceuticals Inc

Sector

Healthcare (1200)

Industry

Drug Manufacturers - Specialty & Generic (87)

Phone

301-838-2500

Address

9715 KEY WEST AVENUE, ROCKVILLE, MD

Employee

652

Twitter

@Supernus_Pharma

Next Earnings Date

2024-11-04

Latest SEC Filings

SUPN's Discussions on Twitter

Compare SUPN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SUPN Supernus Pharmaceuticals Inc	36.99	2.03B	651.97M	59.71M	172.03M	0.73
ZTS Zoetis Inc	176.74	80.59B	9.15B	2.43B	2.31B	4.92
HLN Haleon Plc Adr	9.72	44.17B	14.26B	1.55B	0	0.3327
TAK Takeda Pharmaceutical Co Adr	13.57	42.61B	30.27B	1.93B	3.45B	0.444
TEVA Teva Pharmaceutical Industries Ltd Adr	16.57	18.77B	16.77B	-959.00M	1.37B	-2.00
VTRS Viatris Inc	13.22	15.73B	15.05B	-883.30M	1.89B	1.53

Supernus Pharmaceuticals Inc Stock (SUPN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-11-24	Downgrade	Piper Sandler	Overweight → Neutral
Jan-03-23	Resumed	Jefferies	Buy
Dec-01-21	Resumed	Jefferies	Buy
Apr-13-21	Upgrade	Jefferies	Hold → Buy
Jun-16-20	Upgrade	Piper Sandler	Neutral → Overweight
Jun-15-20	Resumed	Jefferies	Hold
Nov-08-19	Downgrade	Berenberg	Buy → Hold
Nov-07-19	Downgrade	Stifel	Buy → Hold
Nov-06-19	Downgrade	Jefferies	Buy → Hold
Nov-12-18	Reiterated	B. Riley FBR	Buy
Jan-18-18	Reiterated	B. Riley FBR, Inc.	Buy
Dec-28-17	Reiterated	B. Riley FBR, Inc.	Buy
Dec-04-17	Upgrade	Janney	Neutral → Buy
Nov-08-17	Upgrade	Stifel	Hold → Buy
Oct-19-17	Initiated	FBR & Co.	Buy
Sep-19-17	Downgrade	Stifel	Buy → Hold
Jul-17-17	Downgrade	Piper Jaffray	Overweight → Neutral
Jul-14-17	Initiated	Janney	Neutral
Jun-01-17	Upgrade	Piper Jaffray	Neutral → Overweight
Jul-18-16	Downgrade	Northland Capital	Outperform → Market Perform
Jul-18-16	Downgrade	Piper Jaffray	Overweight → Neutral
Feb-08-16	Upgrade	Jefferies	Hold → Buy
Nov-05-15	Reiterated	Northland Capital	Outperform
Oct-28-15	Initiated	Northland Capital	Outperform

View All

Supernus Pharmaceuticals Inc Stock (SUPN) Latest News

Nov 26, 2024

Supernus to Participate in the 36th Annual Piper Sandler Healthcare Conference - GlobeNewswire

Nov 26, 2024

C21 Investments Inc (CXXI-CN) QuotePress Release - The Globe and Mail

Nov 26, 2024

Big Rock Brewery Inc (BR-T) QuotePress Release - The Globe and Mail

Nov 26, 2024

Supernus Pharmaceuticals CEO to Present at Piper Sandler Healthcare Conference | SUPN Stock News - StockTitan

Nov 26, 2024

Supernus to Participate in the 36th Annual Piper Sandler Healthcare Conference - GlobeNewswire Inc.

Nov 26, 2024

Loomis Sayles & Co. L P Reduces Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - MarketBeat

Nov 26, 2024

Nov 25, 2024

Evertz Technologies Ltd (ET-T) QuotePress Release - The Globe and Mail

Nov 25, 2024

Apple Inc (AAPL-Q) QuotePress Release - The Globe and Mail

Nov 25, 2024

Segall Bryant & Hamill LLC Invests $791,000 in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - MarketBeat

Nov 25, 2024

Nov 23, 2024

SUPN (Supernus Pharmaceuticals) Operating Margin % : 22.67% (As of Sep. 2024) - GuruFocus.com

Nov 23, 2024

Connor Clark & Lunn Investment Management Ltd. Has $6.70 Million Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - MarketBeat

Nov 23, 2024

Nov 22, 2024

Pacer Advisors Inc. Buys 403,028 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - MarketBeat

Nov 22, 2024

Nov 21, 2024

Supernus Pharmaceuticals (LTS:0LB2) EBITDA per Share : $2.79 (TTM As of Sep. 2024) - GuruFocus.com

Nov 21, 2024

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q3 2024 Earnings Call Transcript - MSN

Nov 20, 2024

Mutual of America Capital Management LLC Sells 75,782 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - MarketBeat

Nov 20, 2024

Heidrick & Struggl (HSII-Q) QuotePress Release - The Globe and Mail

Nov 20, 2024

Nov 19, 2024

First Mining Gold Corp (FF-T) QuotePress Release - The Globe and Mail

Nov 19, 2024

Aya Gold and Silver Inc (AYA-T) QuotePress Release - The Globe and Mail

Nov 19, 2024

George Weston Limited (WN-T) QuotePress Release - The Globe and Mail

Nov 19, 2024

56,885 Shares in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Bought by State of New Jersey Common Pension Fund D - MarketBeat

Nov 19, 2024

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Purchased by Principal Financial Group Inc. - MarketBeat

Nov 19, 2024

Nov 18, 2024

Argentina Lithium and Energy Corp (LIT-X) QuotePress Release - The Globe and Mail

Nov 18, 2024

Nov 17, 2024

Los Angeles Capital Management LLC Takes Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - MarketBeat

Nov 17, 2024

Nov 15, 2024

(SUPN) Technical Data - Stock Traders Daily

Nov 15, 2024

ARMISTICE CAPITAL, LLC Adjusts Stake in Supernus Pharmaceuticals Inc - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

SUPNSupernus Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan

Nov 14, 2024